Dufenergy may sell Italian commercial arm
It is reported that Dufenergy, the Energy head Company of Duferco Group, is selling its operative Italian commercial arm.
Pfizer has paid $7.5m as regulatory milestone to Auxilium Pharmaceuticals related to the first sale of Xiapex in Germany as a treatment for Dupuytren's contracture.